PC3 prostate tumor-initiating cells with molecular profile FAM65Bhigh/MFI2low/LEF1low increase tumor angiogenesis
2010

Prostate Cancer Stem Cells and Tumor Angiogenesis

Sample size: 10 publication 10 minutes Evidence: moderate

Author Information

Author(s): Zhang Kexiong, Waxman David J

Primary Institution: Boston University

Hypothesis

Can specific molecular profiles of prostate cancer stem cells influence tumor angiogenesis?

Conclusion

PC3 prostate tumors are sustained by a small number of tumor-initiating cells with stem-like characteristics that promote angiogenesis.

Supporting Evidence

  • PC3 holoclones show high self-renewal capability and tumorigenicity.
  • FAM65B is upregulated in holoclones, while MFI2 and LEF1 are downregulated.
  • Tumors from holoclones exhibit increased vascularity compared to parental PC3 tumors.

Takeaway

Some cells in prostate cancer can act like stem cells, helping tumors grow and get more blood vessels.

Methodology

Single cell cloning and spheroid culture studies were used to identify cancer stem-like cells in PC3 prostate cancer cells.

Potential Biases

Potential bias in the selection of cell lines and methods used for identifying cancer stem cells.

Limitations

The study primarily focuses on a single cancer cell line, which may not represent all prostate cancers.

Participant Demographics

Human prostate cancer cell line PC3, originally established from a patient with bone metastasis.

Statistical Information

P-Value

0.005

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1476-4598-9-319

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication